Evidence map›Paper›PMID 36606189›Full record

ArticleJournal of Cancer2022

Erratum: Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway: Erratum.

Li Yuan, Kai Zhang, Meng-Meng Zhou, Harpreet S Wasan, Fang-Fang Tao, Qing-Ying Yan, Guan Feng, Yin-Shan Tang, Min-He Shen, Sheng-Lin Ma and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Li YuanThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, china.
Kai ZhangDepartment of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Zhejiang, China.
Meng-Meng ZhouDepartment of traditional Chinese medicine, The First people's Hospital of Quzhou, 324000, Zhejiang, China.
Harpreet S WasanDepartment of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, W12 0HS, UK.
Fang-Fang TaoDepartment of Immunology and Microbiology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
Qing-Ying YanThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, china.
Guan FengThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, china.
Yin-Shan TangDepartment of Rehabilitation in Traditional Chinese Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Min-He ShenDepartment of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Zhejiang, China.
Sheng-Lin MaDepartment of Oncology, The Forth Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Zhejiang, China.
Shan-Ming RuanDepartment of Medical Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.7150/jca.32873.].

Identifiers

PMID36606189
PMCPMC9809310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.